Takeshi Yaoi

Kyoto Prefectural University of Medicine — Japan

Biochemistry, Genetics and Molecular Biology · Life Sciences

19h-index1.4kcitations68works2.32yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Mitochondrial Function and Pathology(11), Muscle Physiology and Disorders(9), Effects and risks of endocrine disrupting chemicals(7), Epigenetics and DNA Methylation(6), RNA modifications and cancer(6)

Publications68 total

JC Virus Agnogene Regulates Histone-Modifying Enzymes via PML-NBs: Transcriptomics in VLP-Expressing Cells
Viruses·2025Open Access
Clioquinol induces mitochondrial toxicity in <scp>SH</scp> ‐ <scp>SY5Y</scp> neuroblastoma cells by affecting the respiratory chain complex <scp>IV</scp> and <scp>OPA1</scp> dynamin‐like <scp>GTPase</scp>
FEBS Letters·2025· 1 citedOpen Access
Author response for "Clioquinol induces mitochondrial toxicity in &lt;scp&gt;SH&lt;/scp&gt;‐&lt;scp&gt;SY5Y&lt;/scp&gt; neuroblastoma cells by affecting the respiratory chain complex &lt;scp&gt;IV&lt;/scp&gt; and &lt;scp&gt;OPA1&lt;/scp&gt; dynamin‐like &lt;scp&gt;GTPase&lt;/scp&gt;"
2025
Characterization of Dystrophin Dp71 Expression and Interaction Partners in Embryonic Brain Development: Implications for Duchenne/Becker Muscular Dystrophy
Molecular Neurobiology·2025· 2 cited
487P Effect of epithelial-mesenchymal transition status on the efficacy of RAF/MEK clamp and FAK inhibitor combination therapy for KRAS-mutated lung cancer
Annals of Oncology·2024
Epithelial-mesenchymal transition status is a remarkable biomarker for the combination treatment with avutometinib and defactinib in KRAS-mutated non-small cell lung cancer
British Journal of Cancer·2024· 11 citedOpen Access
Loss of Aspm causes increased apoptosis of developing neural cells during mouse cerebral corticogenesis
PLoS ONE·2023· 2 citedOpen Access
Epithelial-mesenchymal transition status is a remarkable biomarker for the combination treatment with avutometinib and defactinib in KRAS-mutated non-small cell lung cancer
Research Square (Research Square)·2023Open Access
Leukemia inhibitory factor shortens primary cilia by upregulating <scp>C‐C</scp> motif chemokine 2 in human neural stem/progenitor cells
Genes to Cells·2023· 1 citedOpen Access
Analysis of Tumor Heterogeneity Through AXL Activation in Primary Resistance to EGFR Tyrosine Kinase Inhibitors
JTO Clinical and Research Reports·2023· 5 citedOpen Access
Characteristic differences in the abundance of tumor-infiltrating lymphocytes and intratumoral developing T cells in thymoma, with special reference to PD-1 expression
Cancer Immunology Immunotherapy·2023· 5 citedOpen Access
Abstract 410: Tumor heterogeneity via AXL activation on primary resistance to EGFR tyrosine kinase inhibitors in EGFR mutated lung cancer
Cancer Research·2023
Dystrophin Short Product, Dp71, Interacts with AQP4 and Kir4.1 Channels in the Mouse Cerebellar Glial Cells in Contrast to Dp427 at Inhibitory Postsynapses in the Purkinje Neurons
Molecular Neurobiology·2023· 19 cited
Low Doses of Bisphenol A Disrupt Neuronal Differentiation of Human Neuronal Stem/Progenitor Cells
ACTA HISTOCHEMICA ET CYTOCHEMICA·2022· 7 citedOpen Access
Loss of abnormal spindle-like, microcephaly-associated (Aspm) disrupts female folliculogenesis in mice during maturation and aging
Reproductive Biology·2022· 8 cited
An autopsy case of <scp>COVID</scp>‐19 with a sudden death: Clinico‐pathological comparison
Clinical Case Reports·2022· 4 citedOpen Access
An autopsy case of COVID-19 with a sudden death : Clinico-pathological comparison.
2022Open Access
Generation of dystrophin short product-specific tag-insertion mouse: distinct Dp71 glycoprotein complexes at inhibitory postsynapse and glia limitans
Cellular and Molecular Life Sciences·2022· 12 citedOpen Access
Generation of Dystrophin Short Product-Specific Tag-Insertion Mouse: Distinct Dp71 Glycoprotein Complexes at Inhibitory Postsynapse and Glia Limitans
Research Square (Research Square)·2021Open Access
MO18-7 Combinatorial treatments of aspirin with glutaminolysis-targeting agents against PIK3CA-mutated colorectal cancer cells
Annals of Oncology·2021
page 1 of 4Next →

Frequent Co-authors

Kyoko Itoh(33), Shinji Fushiki(30), So Tando(8), Takahiro Fujimoto(8), Hiroshi Ogi(5), Madoka Tonosaki(5), Yasuhiro Fujiwara(4), Sachihiko Watanabe(4), Keiko Nakamura(3), Takashi Nakayama(3), Goro Kuwajima(3), Masafumi Umekage(3), Junichi Shimada(3), Kunihiko Terauchi(3), Harukazu Suzuki(3), Akira Fujimori(3), Kenta Nakano(3), Tadashi Okamura(3), Miyuki Mori(3), Seiichiro Okajima(3)